It's not, it's not approved for any other condition
Research on MK 677 is done in controlled laboratory settings with appropriate models and any potential physiological effects are still under scientific investigation
Overall, payers will need to take a collaborative and cooperative approach across provider, PBM, manufacturer and third-party condition management program stakeholders to effectively expand coverage to members
Metabolomic analysis of PC12 cells, using ultra-performance liquid chromatography-quadrupole-time-of-flight mass spectrometry (UPLC-Q/TOF-MS), reveals that catalpol reverses an imbalanced metabolic state by regulating amino acid neurotransmitters, modulating amino acid and energy metabolism, and restoring oxidized substance levels, thus exerting neuroprotective effects (Zhang B
One-year discontinuation was significantly higher for patients without type 2 diabetes (64.8% [95% CI, 64.4%-65.2%]) compared with those with type 2 diabetes (46.5% [95% CI, 46.2%-46.9%])